Key statistics
On Friday, Veracyte Inc (VCYT:NMQ) closed at 34.83, -1.91% below its 52-week high of 35.51, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.98 |
---|---|
High | 35.26 |
Low | 34.35 |
Bid | 30.00 |
Offer | 35.87 |
Previous close | 35.25 |
Average volume | 887.64k |
---|---|
Shares outstanding | 76.81m |
Free float | 76.18m |
P/E (TTM) | -- |
Market cap | 2.68bn USD |
EPS (TTM) | -0.7444 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
- Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
- Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
- Veracyte Announces Second Quarter 2024 Financial Results
- Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
More ▼